Results 21 to 30 of about 6,254,959 (286)
Merck fellowships contribute to the continued growth of clinical pharmacology in Sweden
Since 1990, Merck, Sharpe & Dohme, Sweden, has created fellowships for physicians embarking upon a career in clinical pharmacology at Swedish medical schools.
Sjoqvist, Folke +7 more
core +2 more sources
Integrating pharmacology and clinical pharmacology [PDF]
I here reaffirm some of the points that I made in the manifesto for UK clinical pharmacology [1], in response to letters from others. Much of what I wrote in the manifesto addresses points that correspondents have made, but as some of the important points may not have been clear on a first reading, I shall reiterate them and add clarifications. I am
openaire +2 more sources
Drug development, from preclinical to clinical studies, is a lengthy and complex process. There is an increased interest in the Kingdom of Saudi Arabia (KSA) to promote innovation, research and local content including clinical trials (Phase I-IV ...
Abdullah Alsultan +7 more
doaj +1 more source
Artificial intelligence in clinical dentistry
Background: Artificial intelligence (AI) is increasingly integrated into clinical dentistry, yet ethical, legal, and implementation uncertainties continue to limit its widespread adoption. This study aimed to generate a prioritized, hypothesis-generating
Gowri Sivaramakrishnan, BDS, MDS (Prosthodontics), MFDS (RCSEd), MGDS (RCSI), FDS (RCSEd) +1 more
doaj +1 more source
Clinical Pharmacology of Antibody-Drug Conjugates
Antibody-drug conjugates (ADCs) are biopharmaceutical products where a monoclonal antibody is linked to a biologically active drug (a small molecule) forming a conjugate.
Iftekhar Mahmood
doaj +1 more source
The clinical pharmacology of acamprosate [PDF]
Acamprosate is one of the few medications licensed for prevention of relapse in alcohol dependence, and over time it has proved to be significantly, if moderately, effective, safe and tolerable. Its use is now being extended into other addictions and neurodevelopmental disorders.
Nicola J, Kalk, Anne R, Lingford-Hughes
openaire +2 more sources
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani +7 more
wiley +1 more source
Neonatal Clinical Pharmacology
Similar to other populations, care of neonates strongly relies on robust guidance on neonatal pharmacotherapy, covering an age-appropriate drug formulation, an individualized dose, and information on its efficacy and safety for a specific indication in ...
Karel Allegaert +3 more
doaj +1 more source
The clinical pharmacology of ageing [PDF]
The ageing of populations and individuals continues to be as vital, yet to some extent as neglected, a topic in pharmacology and therapeutics as was first realised about 30 years ago. In parallel with the realisation of the predicted demographic shifts in both the developed and developing world, there have since been major developments in the basic ...
openaire +3 more sources
Evaluation of teaching methods in pharmacology among MBBS students [PDF]
Background: Pharmacology is one of the most important subjects in medical curriculum. It is basis of medical science and the foundation of treatment. The applied aspect forms the basis of clinical rational therapeutics.Methods: A cross-sectional study ...
Tushar R. Bagle +9 more
core +1 more source

